Background. In this study (the first of two related papers), we report whether the relationship between the demographic and anthropometric variables (DA, i.e. age, gender, height and weight) employed in current creatinin (Cr)-based glomerular filtration rate (GFR) estimation equations and actual GFR is mediated by muscle mass. Methods. We studied 77 patients (mean age AE SD, 65.1 AE 11.9 years) with chronic kidney disease (mean GFR 45.7 AE 28.6 ml/min/1.73 m 2 ). Actual GFR was measured by the renal clearance of inulin (GFR inu ). Appendicular lean mass (ALM) and its index (ALMI) by dual energy X-ray absorptiometry provided markers of muscle mass. Multiple regression analyses identified variables explaining variance in (i) GFR, (ii) ALM and (iii) Cr. Results. (i) The DA variables used in the abbreviated modification of diet in renal disease (MDRD) equation accounted for only 59.6% (P < 0.001) of the variance in GFR inu , whilst adding ALMI explained an additional 10.4% variance (P < 0.001). If ALMI was entered first, the relationship between DA variables and GFR inu was reduced (for weight) or completely abolished (for age, gender and height). (ii) After inputting all the commonly used DA variables, 17.2% of the variance in ALM was unexplained. (iii) All the DA variables explained only 60.6% (P < 0.001) of the variance in Cr, whilst adding ALM explained an additional 4.2% variance (P < 0.005). Conclusions. Muscle mass explained more variance in GFR inu than MDRD DA variables and mediated the relationship between GFR inu and DA variables.
Introduction
Accurate measures of glomerular filtration rate (GFR), which provide a useful index of disease severity, are required to help decide when to start dialysis and to estimate correct drug dosage. Yet gold standard measures of GFR remain cumbersome and expensive. Consequently, clinicians and researchers estimate GFR using one of a variety of available prediction equations. These prediction equations include serum creatinine (Cr) because Cr is excreted principally by the kidneys and Cr can be determined cheaply and quickly in clinical practice [1] . Previous researchers [2] [3] [4] have identified that additional variables such as age, gender, ethnicity, height and weight also explain a significant proportion of the variance in kidney function. It is generally accepted that these variables directly affect kidney function [5] [6] [7] and hence these variables, with Cr, are used to predict GFR. However, these variables are also predictors of skeletal muscle mass [8] , the main source of Cr.
Since Cr is the balance of creatinine released from skeletal muscle and is removed by the kidneys, it is possible that the variables currently included in GFR prediction equations, such as age, gender, height, weight and ethnicity, are employed because they are important determinants of muscle mass [8] as well as independent predictors of kidney function. Although previous studies have used body composition to estimate kidney function [9] [10] [11] [12] [13] [14] , none of them have investigated the mediating relationship between the commonly used demographic/anthropometric predictor variables with Cr and GFR, which requires simultaneously investigating relationships between: (i) demographic/anthropometric variables and muscle mass; (ii) demographic/anthropometric variables and GFR; and (iii) muscle mass and GFR, using hierarchial multiple regression analyses. Thus, the first aim of this study was to test the hypothesis that muscle mass mediates a significant proportion of the variance in GFR explained by age, gender, height and weight.
If this hypothesis is true, this may help explain the inaccuracy in GFR estimation shown by previous authors. For example, Beddhu et al. [15] showed that in women of the same age and Cr, and subsequently the same GFR as predicted by the modification of diet in renal disease (MDRD) equation [2] , measured 24 h creatinine excretion varied from 0.5 to 1.5 g/day. Beddhu et al. [15] further suggested that the underlying assumption of the MDRD equation (that age, gender, and ethnicity directly account for creatinine production) was inaccurate because these variables are only indirect measures of muscle mass. Thus, in chronic kidney disease patients with muscle wasting, MDRD estimated GFR is spuriously high [15] .
Therefore, the second aim of this study was to investigate whether the inclusion of a direct measure of muscle mass explains additional variance in GFR than demographic and anthropometric variables alone. This is plausible because demographic and anthropometric variables alone do not take into account the individual variability in muscle mass due to genetics, diet, activity level, disease state and medication use [16] , and thus may lead to inaccuracy in accounting for generation of creatinine. This study was designed to test theoretical hypotheses and not to generate a clinically applicable method of estimating GFR, which is the subject of a companion paper published elsewhere [17] .
Methods
Potential subjects were approached during routine predialysis clinics held between September 2004 and September 2005 at Ysbyty Gwynedd and Ysbyty Glan Clwyd (prospective study, convenience sampling method). Inclusion criteria were the following: age >18 years and presence of chronic kidney disease classified as KDOQI stages 1-4. Patients with GFR >60 ml/min/1.73 m 2 had to show other evidence of kidney damage: albuminuria [two spot urine samples with albumin-creatinine ratio >30 mg albumin/mg creatinine confirmed by overnight urine collections with an excretion rate of 20-200 mg albumin (microalbuminuria) or >200 mg albumin (macroalbuminuria)]: non-urological haematuria, structural abnormalities, or biopsy-proven chronic glomerulonephritis. Exclusion criteria were current dialysis or renal transplant, diabetes, conditions causing significant, uncontrolled clinically apparent oedema, use of medications affecting tubular secretion of creatinine, previous reaction to inulin, severe asthma, inability to lie flat during scanning procedures, cardiac pacemakers and inability to give written informed consent. Ethical approval was obtained from the North Central Wales Local Research Ethics Committee and all the participants gave written informed consent.
Patients presented following overnight fast on two occasions separated by a maximum of 7 days. The day before each visit, patients were requested to minimize alcohol and caffeine intake, ensure adequate hydration and avoid strenuous exercise. During the initial visit, patients attended their renal unit for kidney function assessment and blood letting. The criterion method for measuring GFR was the single shot bolus injection and total body clearance of inulin (GFR inu ). Patients drank 10 ml of water per kg body weight before the procedures began and 100 ml/h thereafter. A cannula was placed in the back of each hand and baseline blood samples were drawn for subsequent analysis of Cr inulin of 2.5 g of 10 ml of 25% Inutest (Fresenius Kabi, Austria) was administered over 3 min through one cannulae before it was removed. Six samples of 4 ml were then drawn into heparinized plastic tubes from the remaining cannuale at 5, 12, 40, 120, 240 and 300 min post-injection. All samples, which were obtained after removing and discarding the initial 2 ml of blood to prevent dilution by the saline flush, were immediately centrifuged and the serum separated and stored at À808C awaiting analysis. Inulin was assayed in plasma by a double enzyme method as previously described [18] (inter-assay CV ¼ 4.1%; intra-assay CV ¼ 1.2%). The reliability of single shot inulin clearances obtained in a group of 12 patients with chronic kidney disease tested on three occasions, each separated by 2 weeks, is reportedly 7.1% [19] . Cr was determined according to a modified Jaffe´method using an autoanalyser (Advia 2400, Bayer, New York, USA); normal range in males ¼ 0.9-1.3 mg/dl and in females ¼ 0.6-1.1 mg/dl; inter-assay CV ¼ 3.2% (n ¼ 31); intra-assay CV ¼ 2.9% (n ¼ 15, at a Cr of 0.8 mg/dl). The reliability of Cr obtained in 17 CKD patients tested over 3 weeks is reportedly >18% [20] .
During the second visit, patients attended the laboratories of the School of Sport, Health and Exercise Sciences at the University of Wales, Bangor for body composition assessment. Subjects voided, changed into a standard hospital gown and were barefoot. Height and weight were measured using a wall mounted stadiometer (Body Care, Warwickshire, UK) and balance scales (Seca, Hamburg, Germany), respectively. Regional and whole body lean and fat masses were assessed by dual energy X-ray absorptiometry (QDR1500, software version 5.72, Hologic, Waltham, USA). To provide a proxy measure of skeletal muscle mass, appendicular lean mass was calculated by summing the lean mass of the four limbs [21] and was expressed as a raw score or normalized by height squared (m 2 ) to give the appendicular lean mass index. Appendicular lean mass is highly correlated with total body skeletal muscle mass [r ¼ 0.96, standard error of the estimate (SEE) ¼ 1.63 kg] because $76% of the appendicular lean mass is in the muscle (the remainder being skin and connective tissue) and because $74% of the total body skeletal muscle mass is in the extremities [21] . Fat mass was expressed as a raw score or normalized by height squared (m 2 , fat mass index) or as a percentage of the total weight (fat%). Since kidney size and function is related to body size, muscle and fat masses were entered in multiple regression analyses as indexes if control for scaling artifacts was required. Reliability data obtained in our lab on a group of nine patients with end-stage kidney disease tested on two occasions separated by 3 months suggests a CV for lean mass by dual energy X-ray absorptiometry of 2.4% and a standard error of measurement of 1.14 kg [22] .
Statistics
All analyses were performed on a statistical computer package (SPSS version 12, Illinios, USA). Values are expressed as means AE SD. For regression, r was used to denote simple Pearson's correlation coefficients, R was used to denote accumulative coefficients from multiple regression analyses and SEE was presented when appropriate.
The principle aim of this study was to test various hypotheses regarding the relationship between Cr, GFR and muscle mass, and not to evaluate the performance of the currently used abbreviated MDRD equation, nor to generate prediction equations for use in clinical practice. We wished to avoid comparing an equation using constants generated on our data set with the MDRD equation, which uses constants generated on a different population, since performance of our equation would, of course, be better as it is specific to our subjects. Therefore, we used multiple regression analyses in an explanatory method to establish the following:
The mediating role of muscle mass between demographic/ anthropometric variables and GFR. (a) Whether demographic/anthropometric variables currently included in prediction equations adequately account for variance in muscle mass (appendicular lean mass) and hence variance in creatinine production (hierarchical method); (b) whether adding a marker of muscle mass would explain extra variance in Cr than all demographic/anthropometric variables (age, gender, height and weight) (hierarchical method); and (c) whether demographic/anthropometric variables explain an independent proportion of variance in GFR inu once a marker of muscle mass had already been entered (hierarchical method).
The importance of muscle mass in explaining variance in GFR. (a) Whether adding a marker of muscle mass (appendicular lean mass) to Cr would explain extra variance in GFR inu than demographic variables currently included in the abbreviated MDRD equation alone (age and genderethnicity was not required as our population were all Caucasian) (hierarchical method); (b) whether adding a marker of muscle mass to Cr would explain extra variance in GFR inu than all the traditionally used demographic/ anthropometric predictor variables alone (age, gender, height and weight) (hierarchical method); and (c) whether a marker of muscle mass would be selected in preference to the demographic/anthropometric variables as a predictor of GFR (stepwise method).
With multiple regression techniques, the following information can be gained: (a) the proportion of variance explained by the whole model (the R 2 value, Table 2 , second column, final row); (b) the proportion of variance accounted for by each predictor variable (the R 2 change value, Table 2 , column 3). Note: only predictors with significant F change statistics ( Table 2 , columns 4 and 5) significantly explain a proportion of variance in the predicted variable; and (c) the nature of the relationship, (including whether positive or negative) between the predicted and the predictor variables (standardized regression coefficients or beta values, Table 2 , columns 6 and 7). In addition, the beta values detail the contribution of each individual predictor variable once all the model steps have been entered [e.g. Table 2 , weight contributed to variance in GFR inu (beta ¼ 0.220, P ¼ 0.025) while age, gender and height did not (P ¼ 0.622-0.975)].
For the multiple regression analyses, assumptions of normality, linearity and homoscedasticity were visually checked by plotting the standardized residuals vs the predicted values. Transformations were made if required but clarity is detailed only when deemed necessary. Multicollinearity was checked by ensuring variance inflation factors did not exceed 100 and predictor variables did not have a condition index exceeding 100 or a condition index exceeding 30 when the predictor variable also contributed 50% of the variance on two or more regression coefficients. Influential outliers on predictor variables were identified using leverage statistics and Cook's distances, and on the predicted variable by standardized residuals >3.0 [23] .
Results
Patient characteristics are detailed in Table 1 . Causes of chronic kidney disease were arteriopathic (n ¼ 11), 
Using predicted GFR by the MDRD equation, we attempted to recruit patients classified as KDOQI stages 1-4. However, when GFR inu was determined, one of our patients was found to be stage 5 (data not excluded). Whilst we did not specifically record blood pressure data, we aim to maintain blood pressure within guidelines as recommended by the Renal Association. The percentage of patients classified as being obese was 29.9% (as defined by a body mass index of >30 kg/m 2 ) or 42.9% (as defined by a fat% by dual energy X-ray absorptiometry of >35% in males and >40% in females). Appendicular lean mass index correlated with weight (r ¼ 0.678, P < 0.001), gender (r ¼ À 0.661, P < 0.001) and height (r ¼ 0.537, P < 0.001) but not age (r ¼ 0.196, P < 0.087).
Multiple regression analyses
The mediating role of muscle mass between demographic/anthropometric variables and GFR.
(a) To determine whether demographic variables (age, gender, height and weight) adequately account for variance in muscle mass (appendicular lean mass), these variables were forced into a hierarchical regression model (Table 2) . Although a significant model was generated (R 2 ¼ 0.828, F (4,72) ¼ 86.46, P < 0.001) and beta values revealed all entered variables explained a significant proportion of variance in appendicular lean mass, 17.2% of the variance in appendicular lean mass was still unaccounted for. Furthermore, the SEE of the estimate of appendicular lean mass prediction was relatively large (2.33 kg). (b) To determine the effect including a measure of body composition has on explaining variance in Cr, the following variables were forced into a hierarchical regression model: GFR inu , age, gender, height and weight plus muscle mass (appendicular lean mass) (R 2 ¼ 0.648, F (6,70) ¼ 21.47, P < 0.001) ( Table 2 ). Forcing in appendicular lean mass explained an additional 4.2% of the variance in Cr. Analysis of beta values revealed only appendicular lean mass and GFR inu significantly contributed to variance in Cr. (c) To determine whether the traditionally used demographic variables would explain extra variance in GFR inu to that explained by muscle mass (appendicular lean mass index), these variables were entered after Cr and appendicular lean mass index into a hierarchical model (Table 2) . Only weight explained additional variance (2.0%) in GFR inu .
The importance of muscle mass in explaining variance in GFR.
(a) To determine the value of adding a measure of body composition to the current MDRD method to predict GFR inu , a hierarchical regression model was generated that included the variables used in the abbreviated MDRD equation (Cr, age and gender) plus muscle mass (appendicular lean mass index) (R 2 ¼ 0.700, F (4,72) ¼ 42.09, P < 0.001, Table 3 ). Forcing in appendicular lean mass index Table 3 ). Excluded variables were height (P ¼ 0.310), age (P ¼ 0.725), gender (P ¼ 0.772) and fat mass (P ¼ 0.845). The following predictive equation was generated:
GFR inu ¼ 1:008 þ ðÀ1:014 Â CrÞ þ ð0:01644 Â ALMÞ þ ð0:07108 Â weightÞ where GFR inu , log 10 transformed glomerular filtration rate by inulin clearance (ml/min); log 10 transformed serum creatinine concentration (mg/dl); ALM, appendicular lean mass; weight, square root transformed weight (kg). The correlation between GFR inu and predicted GFR using appendicular lean mass was r ¼ 0.882 (P < 0.001); the SEE of the estimate was 16.7 ml/min.
Discussion
The present study aimed to test whether muscle mass mediates the relationship between demographic/ anthropometric variables and GFR inu . Using serum creatinine-based measures of kidney function, the relationships between these variables have been extensively researched [5] [6] [7] . However, while many studies admit results may be confounded by altered muscle mass, to the best of our knowledge, no studies have simultaneously taken into account a measure of body composition and used hierarchical multiple regression analyses to investigate the mediating effect of muscle mass on the relationship between demographic/ anthropometric variables and GFR.
Firstly, as has been previously speculated [15] , we empirically showed that demographic/anthropometric variables do not adequately account for variance in muscle mass. In the present data set, demographic variables (age, gender, height and weight) left 17.2% of the variance in appendicular lean mass unexplained, resulting in a relatively large SEE of the appendicular lean mass prediction (2.33 kg). Performance of the demographic variables as used in the abbreviated MDRD equation (just age and gender) was even worse. This is because age, gender, height and weight alone fail to account for other factors that can influence body composition (namely genetics, activity level, diet, disease state and medication use [16] ). Thus relying on demographic/anthropometric variables alone rather than measuring muscle mass directly could lead to errors when accounting for creatinine production and consequently error in GFR estimation.
In accordance with this hypothesis, our data revealed that demographic/anthropometric variables also failed to completely account for variations in Cr. More than 90% of the total body creatine is found in skeletal muscle, wherein an almost constant conversion MDRD, modification of diet in renal disease study; Cr, serum creatinine concentration; ALM/I, appendicular lean mass/index; R 2 , accumulative explained variance in GFR; R of creatine to creatinine occurs (approximately 2 g a day assuming a total of 120 g of creatine in a 70 kg man) which then diffuses from muscle to blood. Theoretically, directly measuring muscle mass will account for more variance in creatinine production. The present data set supports this hypothesis: by adding a marker of muscle mass to GFR inu after accounting for all the commonly used demographic/ anthropometric variables (i.e. age, gender, height and weight), an extra 4.2% of the variance in Cr was explained. Furthermore, we built a hierarchical regression model to predict GFR inu with Cr and muscle mass being entered first. Of the demographic/anthropometric variables subsequently forced in, only weight significantly added to the variance explained in GFR inu . Age did not explain additional variance in GFR inu . While it is generally accepted that GFR declines with age, our data suggest that the relationship of Cr-estimated GFR inu and age is reduced once the variations in muscle mass are accounted for, and that the relationship between Cr-estimated GFR and age is primarily due to the reduction in muscle mass seen with age [16] . In fact, despite a reduction in kidney function, Cr may remain normal due to reduced creatinine generation [6] . Thus, relying on a creatinine based estimation of GFR may be inaccurate if muscle mass is not taken into account.
A similar finding was observed for gender. While female gender is generally believed to be protective against GFR decline (possibly due to hormonal differences) [7] , again our data suggest that the relationship of Cr-estimated GFR inu with gender is reduced once the variations in muscle mass are accounted for. As some females may have higher muscle mass than some males, relying on a creatinine based estimation of GFR and applying a crude correction factor to account for differences in gender will be inaccurate if muscle mass is not directly measured.
However, weight still accounted for some variance in GFR inu once muscle mass had been entered. Weight most likely was entered because our appendicular lean mass derived marker of total body skeletal muscle did not take into account the muscle in the trunk region (which weight would include) or because of a scaling artifact between body size (which is correlated with weight) and kidney size/function. Another potential explanation is the hyperfiltration observed in overweight persons [5] .
Taken together, these findings suggest that muscle does indeed mediate the relationship between demographic/anthropometric variables and Cr-estimated GFR. Thus, our findings provide empirical evidence explaining why demographic/anthropometric variables have been entered in previous equations such as the MDRD formulae, i.e. variables such as age and gender may not only be directly related to kidney function, but primarily correlate with Cr-estimated GFR because muscle mass declines with age and varies with gender. As the prediction of muscle mass using demographic and anthropometric variables is poor, we hypothesized that more variance in GFR would be accounted for if muscle mass was measured directly rather than predicting it.
The second aim of the present study was to test this hypothesis. We found that by adding muscle mass to the demographic variables used in the currently advocated abbreviated MDRD equation (i.e. age and gender), a significant and substantial improvement in the amount of the variance accounted for in measured GFR inu was obtained (10.4%). This is a conservative estimate of improvement because we reduced scaling artifact by entering muscle mass as an index of height; and because we generated our own constants for use with the MDRD equation demographic variables (rather than using actual MDRD generated constants which perform poorly in independent samples such as ours). Even adding a marker of muscle mass to all the commonly used demographic/anthropometric predictor variables (i.e. age, gender, height and weight) still significantly increased the explained variance in GFR inu by 2.4%. Furthermore, using stepwise regression, muscle mass was selected in preference to demographic/anthropometric variables to explain variance in GFR inu .
Thus, these findings provide support for the hypothesis that including a measure of muscle mass will explain more variance in GFR than anthropometric/demographic variables alone. However, it should also be noted that including weight also explained additional variance in GFR inu , albeit to a lesser degree than muscle mass, and albeit possibly causing GFR estimation inaccuracy in patients with abnormal body composition [because of no differentiation between muscle (creatinine generating) and fat (non-creatinine generating) mass]. Finding that weight explained additional variance in GFR is important because the MDRD equation (which does not include anthropometric data) has largely replaced the Cockcroft and Gault equation (that includes weight).
Limitations of the present study include reliance on previously published data for determining reliability and validity of our inulin and creatinine methods. Specifically, total body clearance of inulin (as utilized in the present study) vs urinary clearance may yield higher values. In addition we did not prescribe a meatfree diet preceding the study, possibly reducing reliability of Cr. There may also be error associated with using dual energy X-ray absorptiometry to measure muscle mass when hydration status is altered.
In the present study, we did not wish to develop and validate a prediction equation for estimating GFR. Rather, we wished to test the hypothesis that muscle mass mediates the relationship between demographic/ anthropometric variables and GFR; a hypothesis that our data support. Nevertheless, using a stepwise regression model, an equation was generated utilizing Cr, appendicular lean mass by dual energy X-ray absorptiometry and weight that could be used to estimate GFR. A logical avenue for future research is to develop clinically obtainable measures to predict appendicular lean mass and to determine whether using predicted appendicular lean mass can improve GFR prediction compared with currently advocated GFR equations. Answering this question forms the basis of our companion paper [17] .
In summary, we provide evidence to support the hypothesis that muscle mass mediates the relationship between demographic/anthropometric variables and creatinine-estimated GFR. Consequently, including a measure of muscle mass explained additional variance in GFR than using anthropometric/demographic variables alone. It is probable that by measuring muscle mass, accuracy of GFR estimation equations could be improved, especially in patients with abnormal body composition.
